Literature DB >> 22567188

SlimQuick™ - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity.

Douglas H Weinstein1, William S Twaddell, Jean-Pierre Raufman, Benjamin Philosophe, Ayse L Mindikoglu.   

Abstract

Green tea (Camellia sinensis)-associated hepatotoxicity is reported. However, the presence of alpha-1 antitrypsin MZ phenotype as a predisposing factor to green tea-associated drug-induced liver injury (DILI) is unknown. A previously healthy woman with alpha-1 antitrypsin MZ phenotype who took SlimQuick™, an herbal supplement containing green tea extract, developed severe hepatotoxicity requiring corticosteroid treatment. Green tea-associated hepatotoxicity is reviewed and alpha-1 antitrypsin MZ phenotype as a predisposing factor to green tea-associated DILI is discussed. Liver biopsy demonstrated marked inflammation with necrosis suggestive of toxic injury with diffuse alpha-1 antitrypsin globule deposition on immunostaining. Corticosteroid therapy resulted in rapid clinical improvement. Alpha-1 antitrypsin MZ phenotype may increase vulnerability to herbal hepatotoxicity.

Entities:  

Keywords:  Drug-induced liver injury, Alpha-1-antitrypsin MZ phenotype; Green tea, Hepatotoxicity; SlimQuick™

Year:  2012        PMID: 22567188      PMCID: PMC3345540          DOI: 10.4254/wjh.v4.i4.154

Source DB:  PubMed          Journal:  World J Hepatol


  20 in total

1.  Green tea and cancer.

Authors:  Ian T Johnson
Journal:  Lancet Oncol       Date:  2010-06       Impact factor: 41.316

2.  Serious adverse liver reactions associated with herbal weight-loss supplements.

Authors:  E Bjornsson; Rolf Olsson
Journal:  J Hepatol       Date:  2007-05-29       Impact factor: 25.083

3.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

Authors:  Joshua D Lambert; Mary J Kennett; Shengmin Sang; Kenneth R Reuhl; Jihyeung Ju; Chung S Yang
Journal:  Food Chem Toxicol       Date:  2009-10-31       Impact factor: 6.023

4.  Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.

Authors:  Arie Regev; Constanza Guaqueta; Enrique G Molina; Andrew Conrad; Vishnu Mishra; Mark L Brantly; Maria Torres; Maria De Medina; Andreas G Tzakis; Eugene R Schiff
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

5.  Darkroom hepatitis after exposure to hydroquinone.

Authors:  A K Nowak; K B Shilkin; G P Jeffrey
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

6.  Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype.

Authors:  E D Ruchelli; M Horn; S R Taylor
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

7.  Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans.

Authors:  Gernot Schindler; Ulrich Patzak; Benno Brinkhaus; Alexander von Niecieck; Jörg Wittig; Nils Krähmer; Ingmar Glöckl; Markus Veit
Journal:  J Clin Pharmacol       Date:  2002-08       Impact factor: 3.126

8.  Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency.

Authors:  J Rakela; M Goldschmiedt; J Ludwig
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

Review 9.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Alpha-1-antitrypsin phenotypes in adult liver disease patients.

Authors:  Aleksandra Topic; Tamara Alempijevic; Aleksandra Sokic Milutinovic; Nada Kovacevic
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more
  8 in total

Review 1.  Review of the regulations for clinical research in herbal medicines in USA.

Authors:  Tony Yuqi Tang; Fang-Zhou Li; Janyne Afseth
Journal:  Chin J Integr Med       Date:  2014-11-27       Impact factor: 1.978

Review 2.  Herbal and Dietary Supplement-Induced Liver Injury.

Authors:  Ynto S de Boer; Averell H Sherker
Journal:  Clin Liver Dis       Date:  2016-10-14       Impact factor: 6.126

3.  Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.

Authors:  Elizabeth X Zheng; Simona Rossi; Robert J Fontana; Raj Vuppalanchi; Jay H Hoofnagle; Ikhlas Khan; Victor J Navarro
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

Review 4.  Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.

Authors:  Rolf Teschke; Axel Eickhoff
Journal:  Front Pharmacol       Date:  2015-04-23       Impact factor: 5.810

5.  SlimQuick™-Associated Hepatotoxicity Resulting in Fulminant Liver Failure and Orthotopic Liver Transplantation.

Authors:  Maureen Whitsett; Dina Halegoua-De Marzio; Simona Rossi
Journal:  ACG Case Rep J       Date:  2014-07-08

Review 6.  Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.

Authors:  Miren García-Cortés; Mercedes Robles-Díaz; Aida Ortega-Alonso; Inmaculada Medina-Caliz; Raul J Andrade
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

Review 7.  United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.

Authors:  Hellen A Oketch-Rabah; Amy L Roe; Cynthia V Rider; Herbert L Bonkovsky; Gabriel I Giancaspro; Victor Navarro; Mary F Paine; Joseph M Betz; Robin J Marles; Steven Casper; Bill Gurley; Scott A Jordan; Kan He; Mahendra P Kapoor; Theertham P Rao; Averell H Sherker; Robert J Fontana; Simona Rossi; Raj Vuppalanchi; Leonard B Seeff; Andrew Stolz; Jawad Ahmad; Christopher Koh; Jose Serrano; Tieraona Low Dog; Richard Ko
Journal:  Toxicol Rep       Date:  2020-02-15

Review 8.  Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease.

Authors:  Ayse L Mindikoglu; Antone R Opekun; Sood K Gagan; Sridevi Devaraj
Journal:  Gastroenterol Res Pract       Date:  2017-11-19       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.